UK BioTech company OMass Therapeutics, which develops small-molecule therapeutics against highly validated target ecosystems, has announced an oversubscribed €275 million (£230 million) Series C round. The Round...
Paris-based BioTech company WhiteLab Genomics, which uses AI to design the building blocks of genomic medicines, has closed a €23.2 million ($26 million) Series B funding round....
Paris-based BioTech and AI company Rivercell, which is building proprietary cell-response data infrastructure and a world model that predicts how human cells respond to treatment,...
Gothenburg-based Aventix AB, a bioanalytics company building sensor-based analytical tools for laboratories, has raised €1.2 million ($1.35M) in pre-seed financing. The company is founded by serial entrepreneurs...
Malmö-based startup LivingFilters has raised SEK 4.6 million (€420,000 / $470,000) in a pre-seed funding round led by Turbine Capital, marking an early milestone for the Swedish deep-tech company...
Linköping-based startup PredictMe has secured SEK 5 million (€450,000 / approximately $520,000) in seed funding to accelerate the development of its AI-powered epigenetic diagnostics platform. The investment...
Lund, Sweden — Swedish biotech startup Emulsi Biotech has secured SEK 7 million (€640,000 / $740,000) in a pre-seed funding round led by BSV Ventures, with participation from Almi Invest and two...
Linköping-based biotech startup Celluminova has raised SEK 20 million (~€1.85M / $2.15M) in June 2026 to develop new tools for stem cell research, including applications in cancer stem...
Stockholm-based life science company HAGA.BIO (formerly known as VoxlBio) has raised a SEK 20.9 million (~$2.2–2.3M) seed round in June 2026 to accelerate commercialization of its spatial biology...
Stockholm-based life science company expands clinically validated nutrition portfolio for preterm infants Neobiomics, a Swedish life science company focused on evidence-based nutritional products for...
Nijmegen-based ScreenPoint Medical has secured €13.6 million in fresh funding to accelerate the development of AI-driven solutions for breast cancer detection and risk assessment....
Swedish biotech innovator Cellevate has secured SEK 21.3 million (approximately €2 million / $2.3 million) in fresh funding to accelerate the commercialization of its nanofiber-based cell...
Dortmund-based iDEL Therapeutics has closed a €9 million Seed financing round to advance its pipeline of cancer therapeutics that are delivered directly into the cytosol of...